Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gastrointestinal ultrasound-guided Contezolid in severe gram-positive infection
ChiCTR2300075522Phase 4Not yet recruiting
- Sponsor
- Beijing Huaxin Hospital
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of contezolid in Gram-positive bacterial infection (2 arms), sponsored by Beijing Huaxin Hospital. Primary endpoint: Pharmacokinetic index. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
contezolid
03
Conditions
Gram-positive bacterial infection
Beyond the preview
Go deeper on ChiCTR2300075522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075522.